Neurotech International Ltd. (AU:NTI) has released an update.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Neurotech International Ltd (ASX: NTI) has announced the expiry of its listed options (ASX: NTIOA) on January 30, 2025, with a $0.135 exercise price. Investors have the option to exercise, sell, or let their options lapse before the final trading day on January 23, 2025. This development provides a crucial decision point for stakeholders interested in the company’s innovative biopharmaceutical ventures, particularly in the pediatric neurological disorder space.
For further insights into AU:NTI stock, check out TipRanks’ Stock Analysis page.